An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling
NCT00273702
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Pathological Gambling
Interventions
DRUG:
N-Acetyl Cysteine
Sponsor
University of Minnesota